Claudia Vergara
Rheumatology · Orland Park, ILNPI 1639325848
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 24.7% of the total. Reporting peaked in 2019 at $1,124 and has fallen 98.7% since, to $14 in 2025.
Across 171 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$746
- E.r. Squibb & Sons, L.L.C.$409
- Amgen$381
- Lilly USA, LLC$278
- UCB, Inc.$244
- Mallinckrodt Hospital Products Inc.$194
- plus $766 from 14 others
Across 1 payment — averaging $750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$750
What the payments were for
- Food & beverage$3,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $746 |
| E.r. Squibb & Sons, L.L.C. | 31 | $409 |
| Amgen(2 entities) | 17 | $381 |
| Lilly USA, LLC | 15 | $278 |
| UCB, Inc. | 11 | $244 |
| Mallinckrodt Hospital Products Inc. | 7 | $194 |
| Johnson & Johnson | 10 | $178 |
| Novartis | 3 | $119 |
| Pfizer | 5 | $98 |
| Genentech USA, Inc. | 4 | $75 |
| Sanofi | 4 | $72 |
| Mallinckrodt Enterprises LLC | 3 | $55 |
| Bristol Myers Squibb | 2 | $42 |
| Merck | 2 | $31 |
| GSK | 1 | $22 |
| Radius Health, Inc. | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Fidia Pharma USA Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$104
How this compares
$3,017 in reported general payments places this provider in the 65th percentile of 287 rheumatology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 17 | $123,127 |
| BenlystaBelimumab | 12 | $55,549 |
| Hydroxychloroquine Sulfate | 41 | $1,324 |
| MethotrexateMethotrexate Sodium | 21 | $337 |
| Diclofenac Sodium | 12 | $278 |
| Baclofen | 12 | $144 |
| Alendronate Sodium | 14 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBenlysta | $22 | $55,54912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 287 rheumatology providers in Illinois.
Other rheumatology in Orland Park
- Cory ConniffOrland Park$17K
- Manish JainChicago$1.9M
- Lori SiegelBannockburn$1.5M
- Alfonso BelloGlenview$611K
- Theodore PincusChicago$524K
- Angela CrowleyWillowbrook$483K
- Eric RudermanChicago$440K
- Anisha DuaChicago$280K
- Arthur MandelinChicago$270K
- Jeffrey HorvathSpringfield$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.